Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Merrimack Pharmaceuticals to Present at the 2010 Stifel Nicolaus Healthcare Conference

September 13, 2010 By Bio-Medicine.Org

CAMBRIDGE, Mass., Sept. 13 /PRNewswire/ — Merrimack
Pharmaceuticals today announced that it will present at the Stifel
Nicolaus 2010 Healthcare Conference in Boston. William Sullivan,
Vice President of Finance, will provide a company overview at
11:30am, EDT, Friday, September 17, 2010 at the Four Seasons Hotel
in Boston, Massachusetts.

(Logo:
http://photos.prnewswire.com/prnh/20100913/NE63515LOGO)

(Logo:
http://www.newscom.com/cgi-bin/prnh/20100913/NE63515LOGO)

About MerrimackMerrimack Pharmaceuticals, Inc. is a
biopharmaceutical company dedicated to the discovery and
development of novel medicines for the treatment of cancer and
inflammation. The Company is advancing a robust pipeline of
engineered therapeutics paired with molecular diagnostics.
Merrimack has three oncology candidates in clinical development:
MM-121, partnered with sanofi-aventis, in Phase 2 clinical testing,
MM-111 in Phase 1/2 clinical testing, MM-398, partnered with
PharmaEngine, Inc., in Phase 2 clinical testing and multiple
pre-clinical development and research stage programs in the
pipeline. MM-121, MM-111, and MM-398 are investigational drugs and
have not been approved by the U.S. Food and Drug Administration or
any international regulatory agency. The Company’s proprietary
Network Biology discovery platform, developed with the help of
leading scientists from MIT and Harvard, integrates the fields of
engineering, biology and computing to enable mechanism-based model
driven discovery and development of both therapeutics and
diagnostics. Merrimack is a privately-held company based in
Cambridge, Massachusetts. For additional information, please visit
http://www.merrimackpharma.com.
ContactsKathleen Petrozzelli, Corporate Communications,
617-441-1043,
kpetrozzelli@merrimackpharma.com
, http://www.merrimackpharma.com
Betsy Ra

‘/>”/>

SOURCE

Related Articles Read More >

Engineer inspecting artificial hip joint parts in quality control department in orthopaedic factory
Deburring and finishing for beautiful, functional medical devices
A Medtronic HVAD pump opened up to show the inner workings
FDA designates new Medtronic HVAD pump implant recall as Class I
Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age

DeviceTalks Weekly.

June 24, 2022
How innovative design, commercial strategy is building Cala Trio’s bioelectronic medicine market
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech